IP Library Granted Patent US 12,569,175
Granted Patent B2
US 12,569,175 · App. 17/765,266 · Granted Mar 10, 2026

Blood components collection and separation media, blood components collection and separation device comprising said media, and blood components separation and extraction process implementing said media

Inventors: Frédéric Bebien (Jardin, FR); Stéphanie Pigeot Remy (Sainte Colombe, FR)
Assignee: AHLSTROM OYJ
A61B5/150755B01D39/163B01D39/2024G01N33/491B01D2239/0421B01D2239/086B01D2239/1208B01D2239/1216
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,569,175
App. No.
17/765,266
Granted
Mar 10, 2026
Kind
B2
Abstract

The present invention relates to a blood components collection and separation media ( 1 ) comprising a substrate ( 3 ) having a maximal flow pore size enabling the retention of at least red cells on the surface of the substrate ( 3 ), the blood components collection and separation media ( 1 ) comprises boundary walls ( 7 ) forming a pattern ( 9 ) and being made of a hydrophobic resin, and the pattern ( 9 ) presenting: a collection zone ( 91 ); at least one storage zone ( 93 ) aimed at collecting at least one component of the whole blood sample ( 5 ); and at least one channel ( 95 ) connecting the collection zone ( 91 ) to the at least one storage zone ( 93 ), the channel ( 95 ) forming a bottleneck between the collection zone ( 91 ) and the storage zone ( 93 ). The present invention further relates to a blood components collection and separation device and a blood components separation and extraction process.

Claims (33)

1 . Blood components collection and separation media ( 1 ) comprising: a substrate ( 3 ) configured to be wetted by a whole blood sample ( 5 ), the substrate ( 3 ) having a maximal flow pore size comprised between 8 μm and 35 μm, such maximal flow pore size enabling the retention of at least red cells ( 51 ) on the surface of the substrate ( 3 ), characterized in that the blood components collection and separation media ( 1 ) further comprises boundary walls ( 7 ) extending at least through a whole depth (d) of the substrate ( 3 ) which is a fibrous web and which forms a pattern ( 9 ) into said substrate ( 3 ), said boundary walls ( 7 ) being made of a hydrophobic resin, and in that the pattern ( 9 ) within the substrate ( 3 ) and formed by the boundary walls ( 7 ) comprises:

a collection zone ( 91 ) aimed at receiving the whole blood sample ( 5 );

at least one storage zone ( 93 ) aimed at collecting at least one component of the whole blood sample ( 5 ) after its separation through the substrate ( 3 ); and

at least one channel ( 95 ) connecting the collection zone ( 91 ) to the at least one storage zone ( 93 ), the at least one channel ( 95 ) forming a bottleneck between the collection zone ( 91 ) and the at least one storage zone ( 93 ).

2 . Blood components collection and separation media ( 1 ) according to claim 1 , wherein the substrate ( 3 ) has a mean flow pore size comprised between 2.5 μm and 5 μm.

3 . Blood components collection and separation media ( 1 ) according to claim 1 , wherein the hydrophobic resin forming the boundary walls ( 7 ) is chosen among photo-curable resins, UV-curable resins, or thermosetting resins.

4 . Blood components collection and separation media ( 1 ) according to claim 1 , wherein the hydrophobic resin is chosen among fluorinated resins, modified fluorinated resins, latexes, glycol ether acrylates, acrylate esters, or a combination thereof.

5 . Blood components collection and separation media ( 1 ) according to claim 1 , wherein the collection zone ( 91 ) of the pattern ( 9 ) has a substantially parallelogram shape; and

wherein the at least one storage zone ( 93 ) is disposed at an angle ( 97 ) of the substantially parallelogram shape of the collection zone ( 91 ); and

wherein the pattern ( 9 ) comprises as many storage zones ( 93 ) as the collection zone ( 91 ) has channels ( 95 ).

6 . Blood components collection and separation media ( 1 ) according to claim 1 , wherein the at least one storage zone ( 93 ) has a substantially circular shape.

7 . Blood components collection and separation media ( 1 ) according to claim 1 , wherein the at least one channel ( 95 ) has a length ( 1 ) comprised between 1 mm and 5 mm and a width (w) comprised between 1 mm and 3 mm.

8 . Blood components collection and separation media ( 1 ) according to claim 1 , wherein the fibrous web comprises:

first fibers, said first fibers being chosen among glass micro-fibers or synthetic micro-fibers;

second fibers, said second fibers being chosen among fibrillated fibers; and

a hydrophilic binder.

9 . Blood components collection and separation media ( 1 ) according to claim 8 , wherein the hydrophilic binder is at least one of latex binders, polyvinyl alcohol binders, styrene-butadiene binders, vinyl-acetate binders, polysaccharide binders or protein binders.

10 . Blood components collection and separation media ( 1 ) according to claim 8 , wherein the fibrous web comprises between 5 and 7% by weight of the hydrophilic binder.

11 . Blood components collection and separation media ( 1 ) according to claim 1 , wherein the boundary walls ( 7 ) forming the pattern ( 9 ) exceed one surface of the substrate ( 3 ).

12 . Blood components collection and separation media ( 1 ) according to claim 1 , wherein the collection zone ( 91 ) further contains a salt capable of achieving at least partial crenation of red cells ( 51 ), the salt being chosen from the group of alkali metal and alkaline earth metal halogenides and sulfates, and hydrochlorides of organic bases.

13 . Blood components collection and separation device ( 10 ), aimed at separating and collecting at least one component of a whole blood sample ( 5 ), wherein the blood components collection and separation device ( 10 ) comprises at least the blood components collection and separation media ( 1 ) according to claim 1 and a frame ( 11 ) surrounding the blood components collection and separation media ( 1 ).

14 . Blood components separation and extraction process ( 100 ), wherein the process ( 100 ) implements a blood components collection and separation media ( 1 ) according to claim 1 and the process ( 100 ) comprises the following steps:

depositing (S 1 ) of a whole blood sample ( 5 ) in the collection zone ( 91 );

absorbing (S 3 ) of the whole blood sample ( 5 ) onto the substrate ( 3 );

retaining (S 5 ) of the red cells ( 51 ), the platelets ( 52 ) and the white cells ( 53 ) on the substrate ( 3 ) in the collection zone ( 91 );

diffusing (S 7 ) of at least one component through the substrate ( 3 ) to the at least one storage zone ( 93 ); and

extracting (S 9 ) at least one target component stored in the substrate ( 3 ) of the blood components collection and separation media ( 1 ).

15 . Blood components separation and extraction process ( 100 ) according to claim 14 , wherein the at least one target component is stored in the at least one storage zone ( 93 ) and wherein the extraction step (S 9 ) of said at least one target component is performed by punching at least one part of said at least one storage zone ( 93 ) or by eluting said at least one target component from the at least one storage zone ( 93 ).

16 . Blood components separation and extraction process ( 100 ) according to claim 14 , wherein the at least one target component is stored in the collection zone ( 91 ) and wherein the extraction step (S 9 ) of said at least one target component is performed by punching at least one part of said collection zone ( 91 ) or by eluting said at least one target component from the collection zone ( 91 ).

17 . Blood components separation and extraction process ( 100 ) according to claim 14 , wherein the whole blood sample ( 5 ) deposited in the collection zone ( 91 ) has a volume comprised between 50 μL and 500 μL.

18 . Blood components separation and extraction process ( 100 ) according to claim 14 , wherein the target component aimed at being extracted from the whole blood sample ( 5 ) is plasma ( 55 ).

19 . Blood components separation and extraction process ( 100 ) according to claim 14 , wherein the target component aimed at being extracted from the whole blood sample ( 5 ) is DNA, said DNA being stored in the white cells ( 53 ).

20 . Blood components separation and extraction process ( 100 ) according to claim 14 , wherein the target component aimed at being extracted from the whole blood sample ( 5 ) is lipids, said lipids being stored in the red cells ( 51 ).

Assignments (2)
CHANGE OF NAME Recorded Apr 21, 2023
From: AHLSTROM-MUNKSJÖ OYJ
To: AHLSTROM OYJ
Reel/Frame 063426/0717 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 13, 2022
From: BEBIEN, FRÉDÉRIC; PIGEOT REMY, STÉPHANIE
To: AHLSTROM-MUNKSJO OYJ
Reel/Frame 060497/0733 →
Continuity (1)
Related Publication 20220338770A1 · Oct 27, 2022
References Cited (29)
US 4477575A · Vogel et al. · 1984 [cited by applicant]
US 4816224A · Vogel et al. · 1989 [cited by applicant]
US 5186843A · Baumgardner et al. · 1993 [cited by applicant]
US 5454946A · Heagle et al. · 1995 [cited by applicant]
US 6036659A · Ray · 2000 [cited by examiner]
US 9539572B2 · Blankenstein et al. · 2017 [cited by applicant]
US 10386356B2 · Kelso et al. · 2019 [cited by applicant]
US 20020053548A1 · Lee et al. · 2002 [cited by applicant]
US 20060204403A1 · Federas · 2006 [cited by applicant]
US 20070102362A1 · Iida · 2007 [cited by examiner]
US 20070178521A1 · Sakaino et al. · 2007 [cited by applicant]
US 20100092979A1 · Kelso · 2010 [cited by examiner]
US 20140017124A1 · Lee et al. · 2014 [cited by applicant]
US 20150014185A1 · Neijzen et al. · 2015 [cited by applicant]
US 20150060353A1 · Neijzen et al. · 2015 [cited by applicant]
US 20160109467A1 · Kolb et al. · 2016 [cited by applicant]
US 20180207564A1 · Hennessey · 2018 [cited by applicant]
US 20210068730A1 · Johnson · 2021 [cited by examiner]
US 20210378567A1 · Weidemaier et al. · 2021 [cited by applicant]
US 20220268675A1 · Henion et al. · 2022 [cited by applicant]
US 20220273209A1 · Anderson · 2022 [cited by examiner]
CN 103285949A · 2013 [cited by applicant]
CN 106770520A · 2017 [cited by applicant]
CN 108646012A · 2018 [cited by applicant]
WO 2015014974A1 · 2015 [cited by applicant]
WO 2017017314A1 · 2017 [cited by applicant]
International Search Report for International Application No. PCT/FI2019/050708; International Filing Date Oct. 2, 2019; Date of Mailing Jun. 4, 2020; 4 pages. [cited by applicant]
Written Opinion for International Application No. PCT/FI2019/050708; International Filing Date Oct. 2, 2019; Date of Mailing Jun. 4, 2020; 5 pages. [cited by applicant]
Chinese Office Action for the corresponding Chinese Application No. 201980102257.9, Date of Mailing: Oct. 8, 2024; 11 pages (no English translation). [cited by applicant]